794518-59-5 Usage
Description
(S)-2-(benzylamino)-3-((tert-butyldimethylsilyl)oxy)propan-1-ol is a chiral secondary alcohol derivative with the molecular formula C17H31NO2Si. It features a benzylamino group and a tert-butyldimethylsilyl ether group, which contribute to its unique chemical properties and reactivity. (S)-2-(benzylamino)-3-((tert-butyldimethylsilyl)oxy)propan-1-ol is widely recognized for its applications in organic synthesis, particularly as a chiral auxiliary in the asymmetric synthesis of various chemical compounds. Its structural versatility and chiral nature also make it a valuable tool in asymmetric synthesis and catalysis, with potential applications in the development of new molecules for pharmaceuticals, agrochemicals, and other industries.
Uses
Used in Pharmaceutical Industry:
(S)-2-(benzylamino)-3-((tert-butyldimethylsilyl)oxy)propan-1-ol is used as a chiral auxiliary for the asymmetric synthesis of pharmaceutical compounds. Its unique structure allows for the creation of complex molecules with specific stereochemistry, which is crucial for the development of effective and selective drugs.
Used in Agrochemical Industry:
In the agrochemical industry, (S)-2-(benzylamino)-3-((tert-butyldimethylsilyl)oxy)propan-1-ol is utilized as a chiral building block for the synthesis of biologically active molecules. Its ability to participate in various chemical reactions enables the development of novel agrochemicals with improved performance and selectivity.
Used in Organic Synthesis:
(S)-2-(benzylamino)-3-((tert-butyldimethylsilyl)oxy)propan-1-ol is employed as a versatile building block in organic synthesis. Its participation in a range of chemical reactions facilitates the creation of new molecules with potential applications in various industries, including pharmaceuticals, agrochemicals, and materials science.
Used in Asymmetric Synthesis and Catalysis:
Due to its chiral nature, (S)-2-(benzylamino)-3-((tert-butyldimethylsilyl)oxy)propan-1-ol is used as an important tool in the field of asymmetric synthesis and catalysis. It aids in the development of enantioselective catalysts and processes, which are essential for producing optically active compounds with high purity and selectivity.
Check Digit Verification of cas no
The CAS Registry Mumber 794518-59-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,9,4,5,1 and 8 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 794518-59:
(8*7)+(7*9)+(6*4)+(5*5)+(4*1)+(3*8)+(2*5)+(1*9)=215
215 % 10 = 5
So 794518-59-5 is a valid CAS Registry Number.
794518-59-5Relevant articles and documents
HIV PROTEASE INHIBITORS
-
, (2015/07/07)
The present invention is directed to 5-heteroarylmorpholine derivatives and their use in the inhibition of HIV protease, the inhibition of HIV replication, the prophylaxis of infection by HIV, the treatment of infection by HIV, and the prophylaxis, treatment, and delay in the onset or progression of AIDS. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.
Total synthesis of (-)-α-kainic acid by (-)-sparteine-mediated asymmetric deprotonation-cycloalkylation
Martinez, M. Montserrat,Hoppe, Dieter
, p. 3743 - 3746 (2007/10/03)
(Chemical Equation Presented) We report a new enantioselective synthesis of (-)-α-kainic acid from D-serine methyl ester hydrochloride, based on a (-)-sparteine-mediated asymmetric deprotonation of an intermediate carbamate that, by stereospecific anti SN′SE′ intramolecular cycloalkylation, leads to the pyrrolidine ring precursor of (-)-α-kainic acid, in high yield and diastereoselectivity. The intermediate pyrrolidine was further transformed to (-)-α-kainic acid in three steps.
